Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2004
05/20/2004US20040096877 For diagnosis/treatment/prevention of inflammation/asthma/ allergies
05/20/2004US20040096467 Drug, in particular for modulating the immunological response for the control of viruses, tumors, bacteria and parasites
05/20/2004US20040096452 Multivalent vaccines for the treatment of B-cell malignancies (e.g., lymphomas and leukemias) . The present invention also provides methods for the production of custom vaccines, including multivalent vaccines for the treatment of immune
05/20/2004US20040096451 Preventing, treating or ameliorating symptoms associated with respiratory syncytial virus (RSV), parainfluenza virus (PIV), and/or human metapneumovirus (hMPV) infection, the methods comprising administering to a subject an effective amount of
05/20/2004US20040096450 Determining the prophylactic suitability and quality control of compositions, such as intravenous immunoglobulin mixtures and Fac proteins for use in such methods, of preparing compositions for treating such disorders.
05/20/2004US20040096449 Monoclonal antibodies against N-Terminus proBNP
05/20/2004US20040096448 Nucleic acid molecules encoding a protein interacting with ser/thr kinase akt
05/20/2004US20040096447 Preventives/remedies for thickened scar, keloid or chronic arthritic diseases
05/20/2004US20040096446 Methods for treating demyelinating diseases
05/20/2004US20040096444 Identification of the endothelial receptor for the angiostatin kringle-5
05/20/2004US20040096442 Modified anti-egfr antibodies with reduced immunogenicity
05/20/2004US20040096440 Water-soluble globulin concentrate for improving growth in animals
05/20/2004US20040096439 A hybridoma cell line 6G11-F11-D12, deposited with American Type Culture Collection under Accession Number PTA-4844 and monoclonal antibodies
05/20/2004US20040096435 Methods for screening compounds that modulate lipid metabolism
05/20/2004US20040096392 Antibodies against cancer antigen TMEFF2 and uses thereof
05/19/2004EP1420032A1 Antibody recognizing gm1 ganglioside-bound amyloid beta-protein and dna encoding the antibody
05/19/2004EP1420031A2 Bone morphogenetic protein (BMP)-18 compositions
05/19/2004EP1419393A1 Tumor specific oligosaccharide sequences and use thereof
05/19/2004EP1419274A1 Modular assembly of nucleic acid-protein fusion multimers
05/19/2004EP1419264A2 Kinases and phosphatases
05/19/2004EP1419254A2 Genetic products of ashbya gossypii, associated with transmembrane transport
05/19/2004EP1419249A2 TIMM8b-RELATED PROTEIN
05/19/2004EP1419236A2 Methods for treating or preventing sclerotic disorders using cd2-binding agents
05/19/2004EP1419179A2 Antigen binding domains from fish
05/19/2004EP1419175A2 Replikin peptides and uses thereof
05/19/2004EP1418943A1 Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
05/19/2004EP1418940A2 Dna expression vectors and methods of use
05/19/2004EP1418931A1 New drug
05/19/2004EP1418834A2 Methods for diagnosing and treating alzheimer's disease and parkinson's disease
05/19/2004EP1418813A2 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
05/19/2004EP1418808A1 Imaging marker transgenes
05/19/2004EP1229936B1 Use of anti-idiotypical antibodies as vaccines against cancer
05/19/2004EP1137935B1 Detection of preharvest sprouting in cereal grains
05/19/2004EP1082137A4 REVERSAL OF PROINFLAMMATORY RESPONSE BY LIGATING THE MACROPHAGE Fc$g(g)RI RECEPTOR
05/19/2004EP1037927B1 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
05/19/2004EP1017810B1 Agonist and antagonist peptides of carcinoembryonic antigen (cea)
05/19/2004EP0993616B1 Reagent for detecting and monitoring viral infections
05/19/2004EP0970372B1 Assay for disease related conformation of a protein
05/19/2004EP0870026B1 Ob protein derivatives having prolonged half-life
05/19/2004EP0801572B1 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin
05/19/2004EP0787190B1 Hepatitis e virus antigens and uses therefor
05/19/2004EP0682703B1 HTLV-I AND HTLV-II gp21 DERIVED PEPTIDES FOR USE IN DIAGNOSTICS
05/19/2004CN1498222A Steroidal derivatives
05/19/2004CN1496974A Chloramineone and haptene, immuongen, antibody and coupler of its metabolite
05/19/2004CN1150331C A group of efficient expression carriers for humanized antibody of mummal cell
05/19/2004CN1150324C Novel human lysozyme gene, its encoding polypeptide and the method preparing for them
05/19/2004CN1150318C Intracelluar domain of the HER-2/neu protein for prevention or treatment of malignancies
05/19/2004CN1150209C Single-chain antiboby Al for recognizing white-spot baculovirus of prawn and its usgae
05/19/2004CN1150207C Gclq receptor, HIV-1 ph120 region binding thereto, and related peptides and targeting antibodies
05/18/2004US6737514 Compositions and methods for the therapy and diagnosis of lung cancer
05/18/2004US6737513 Macrophage derived chemokine (MDC) and chemokine analogs and assay to identify modulators of MDC activity, and therapeutic uses for same
05/18/2004US6737506 For modulating oxidative damage to intracellular components such as mitochondrial dna (mtdna) and mitochondrial protein
05/18/2004US6737398 Administering tumor necrosis factor-alpha directly to lung tissue
05/18/2004US6737267 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof
05/18/2004US6737249 Agonist antibodies
05/18/2004US6737248 Apparatus for use in the detection of bacterial infections
05/18/2004US6737243 Determination of the hydrophobic pulmonary surfactant protein SP-C
05/18/2004US6737233 Method for preparing HCV E2 binding protein
05/18/2004US6737232 IAPs associated cell cycle proteins, compositions and methods of use
05/18/2004US6737063 Immunological polypeptides; vaccine against gramnegative bacteria
05/18/2004US6737062 Immunogenic compositions
05/18/2004US6737061 Antibody for use in the diagnosis and treatment of cancer
05/18/2004US6737060 High affinity humanized anti-TAG-72 monoclonal antibodies
05/18/2004US6737059 Methods of inhibiting inflammatory processes and alleviating symptoms associated with multiple sclerosis
05/18/2004US6737058 Methods for inhibiting endothelial cell and fibrinogen mediated inflammation using fibrinogen specific antibodies
05/18/2004US6737057 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
05/18/2004US6737056 Polypeptide variants with altered effector function
05/18/2004US6737040 Method and antibody for imaging breast cancer
05/18/2004CA2343719C New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof
05/18/2004CA2343715C New human growth differentiation factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof
05/18/2004CA2042945C Protein purification method
05/13/2004WO2004040398A2 Use of a computer to design a molecule
05/13/2004WO2004040262A2 Compositions and methods for modifying toxic effects of proteinaceous compounds
05/13/2004WO2004039982A1 Enzymes dephosphorylating actin depolymerizing factor cofilin and genes thereof
05/13/2004WO2004039976A1 Novel glycosyltransferase, nucleic acid encoding the same and method of detecting cancer tissue using the nculeic acid
05/13/2004WO2004039963A2 Antibodies specific for phosphorylated insulin receptor substrate-1/2 (ser 1101/ser1149) and uses thereof
05/13/2004WO2004039952A2 Methods of use for novel human polypeptides encoded by polynucleotides
05/13/2004WO2004039951A2 Il-1 receptor based antagonists and methods of making and using
05/13/2004WO2004039845A1 Antimicrobial lipase antibodies their nucleotide and aminoacid sequences and uses thereof
05/13/2004WO2004039844A1 Prostate cancer tumor marker
05/13/2004WO2004039842A2 Humanized tissue factor antibodies
05/13/2004WO2004039841A2 Trimeric binding proteins for trimeric cytokines
05/13/2004WO2004039840A1 Chimeric cytoplasmic signalling molecules
05/13/2004WO2004039402A2 Prevention and treatment of porcine reproductive and respiratory syndrome with the use of immunoglobulins obtained from the egg yolk from hens hyperimmunised with the prrs virus
05/13/2004WO2004039401A2 Use of antibodies to the gamma 2 chain of lallminin 5 to inhibit tumor growth and metastasis
05/13/2004WO2004039337A2 Stable liquid pharmaceutical formulation of antibodies that are prone to isomerization
05/13/2004WO2004039307A2 Methods and compositions for diagnosing and treating companion animal cancer
05/13/2004WO2004039244A2 Methods and kits for diagnosing tumorigenicity
05/13/2004WO2004039234A2 Humanized antibodies against the venezuelan equine encephalitis virus
05/13/2004WO2003093447A3 Microglial inactivation
05/13/2004WO2003089472A3 Anti-nls scfv and peptides and uses thereof in nuclear import inhibition
05/13/2004WO2003087838A8 Compositions, methods and kits for immunochemical determination of mannan-binding lectin (mbl)
05/13/2004WO2003079750A3 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
05/13/2004WO2003070190A3 Surrogate antibodies and methods of preparation and use thereof
05/13/2004WO2003066891A3 Genetic markers for the diagnosis of the expression of inverted nipples in pets, breeding animals and domestic cattle
05/13/2004WO2003057014A3 Biomarkers for detecting ovarian cancer
05/13/2004WO2003053921A9 Mutant proteinase inhibitors and uses thereof
05/13/2004WO2003052050A3 P450 enzymes, nucleic acids encoding them and methods of making and using them
05/13/2004WO2003034903B1 Psma antibodies and protein multimers
05/13/2004WO2003005636A8 Secure header information for multi-content e-mail